CELC

Celcuity Inc.

Services-Medical Laboratories · SIC 8071CIK 1603454Held by 5 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

—

Net Income FY2025

$(177.0M)

EPS (Basic, as reported)

$-3.79

Net Margin FY2025

—

ROE FY2025

-176.1%

Total Equity

$101.0M

Shares Out

49M

Business description

Celcuity Inc. — Services-Medical Laboratories. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2016–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itNet income: (3) → (177)

Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022⚑FY2023⚑FY2024FY2025

Research & development(3)(5)(6)(6)(8)(26)(35)(61)(104)(145)

General & administrative0(1)(2)(2)(2)(3)(4)(6)(9)(27)

Total operating expenses(3)(6)(8)(8)(10)(28)(39)(66)(113)(172)

Operating income(3)(6)(8)(8)(10)(28)(39)(66)(113)(172)

Interest expense00000(1)(2)(5)(10)(17)

Interest & investment income000000181212

Other income (expense), net00000(1)(1)21(5)

Pre-tax income(3)(6)(7)(7)(9)(30)(40)(64)(112)(177)

Income tax expense00000—————

Net income(3)(6)(7)(7)(9)(30)(40)(64)(112)(177)

EPS — basic—————($2.21)($2.64)($2.69)($2.83)($3.79)

EPS — diluted——————($2.64)($2.69)($2.83)($3.79)

Shares outstanding — basic (M)—————1315243947

Shares outstanding — diluted (M)——————15243947

⚑ Weighted-average shares changed ×1.60 between FY2022 and FY2023 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.
⚑ Weighted-average shares changed ×1.63 between FY2023 and FY2024 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.